Global Influenza Virus Vaccine (H1N1) Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: May-2021 | Id: MACRC-63502 | Geographical Scope: Global | Publisher: HNY Research
The global Influenza Virus Vaccine (H1N1) market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: CSL Hualan Bio-Vaccine Medimmune NVS(Novartis) Beijing Kexing Bio-Vaccine Sanofi Pasteur Beijing Tiantan Bio-Products Baxter GSK Changchun Changsheng Bio-Technology Jiangsu Yanshen Bio-Technology Sinopharm Zhejiang Tianyuan Bio-Pharmaceutical Dalian Yalifeng Bio-Pharmaceutical By Types: Intramuscular Vaccine Nasal Spray Vaccine By Applications: 3 To 10 Years Old 10 To 18 Years Old Above 18 Years Old Other Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Influenza Virus Vaccine (H1N1) Revenue 1.5 Market Analysis by Type 1.5.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Intramuscular Vaccine 1.5.3 Nasal Spray Vaccine 1.6 Market by Application 1.6.1 Global Influenza Virus Vaccine (H1N1) Market Share by Application: 2022-2027 1.6.2 3 To 10 Years Old 1.6.3 10 To 18 Years Old 1.6.4 Above 18 Years Old 1.6.5 Other 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Influenza Virus Vaccine (H1N1) Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Influenza Virus Vaccine (H1N1) Market Players Profiles 3.1 CSL 3.1.1 CSL Company Profile 3.1.2 CSL Influenza Virus Vaccine (H1N1) Product Specification 3.1.3 CSL Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Hualan Bio-Vaccine 3.2.1 Hualan Bio-Vaccine Company Profile 3.2.2 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Specification 3.2.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Medimmune 3.3.1 Medimmune Company Profile 3.3.2 Medimmune Influenza Virus Vaccine (H1N1) Product Specification 3.3.3 Medimmune Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 NVS(Novartis) 3.4.1 NVS(Novartis) Company Profile 3.4.2 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Specification 3.4.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Beijing Kexing Bio-Vaccine 3.5.1 Beijing Kexing Bio-Vaccine Company Profile 3.5.2 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Specification 3.5.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Sanofi Pasteur 3.6.1 Sanofi Pasteur Company Profile 3.6.2 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Specification 3.6.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Beijing Tiantan Bio-Products 3.7.1 Beijing Tiantan Bio-Products Company Profile 3.7.2 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Specification 3.7.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Baxter 3.8.1 Baxter Company Profile 3.8.2 Baxter Influenza Virus Vaccine (H1N1) Product Specification 3.8.3 Baxter Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 GSK 3.9.1 GSK Company Profile 3.9.2 GSK Influenza Virus Vaccine (H1N1) Product Specification 3.9.3 GSK Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 Changchun Changsheng Bio-Technology 3.10.1 Changchun Changsheng Bio-Technology Company Profile 3.10.2 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Specification 3.10.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 Jiangsu Yanshen Bio-Technology 3.11.1 Jiangsu Yanshen Bio-Technology Company Profile 3.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Specification 3.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 Sinopharm 3.12.1 Sinopharm Company Profile 3.12.2 Sinopharm Influenza Virus Vaccine (H1N1) Product Specification 3.12.3 Sinopharm Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 Zhejiang Tianyuan Bio-Pharmaceutical 3.13.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Profile 3.13.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Specification 3.13.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.14 Dalian Yalifeng Bio-Pharmaceutical 3.14.1 Dalian Yalifeng Bio-Pharmaceutical Company Profile 3.14.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Specification 3.14.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Influenza Virus Vaccine (H1N1) Market Competition by Market Players 4.1 Global Influenza Virus Vaccine (H1N1) Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Market Players (2016-2021) 4.3 Global Influenza Virus Vaccine (H1N1) Average Price by Market Players (2016-2021) 5 Global Influenza Virus Vaccine (H1N1) Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Influenza Virus Vaccine (H1N1) Market Size (2016-2021) 5.1.2 Influenza Virus Vaccine (H1N1) Key Players in North America (2016-2021) 5.1.3 North America Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) 5.1.4 North America Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Influenza Virus Vaccine (H1N1) Market Size (2016-2021) 5.2.2 Influenza Virus Vaccine (H1N1) Key Players in East Asia (2016-2021) 5.2.3 East Asia Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) 5.2.4 East Asia Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Influenza Virus Vaccine (H1N1) Market Size (2016-2021) 5.3.2 Influenza Virus Vaccine (H1N1) Key Players in Europe (2016-2021) 5.3.3 Europe Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) 5.3.4 Europe Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Influenza Virus Vaccine (H1N1) Market Size (2016-2021) 5.4.2 Influenza Virus Vaccine (H1N1) Key Players in South Asia (2016-2021) 5.4.3 South Asia Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) 5.4.4 South Asia Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Influenza Virus Vaccine (H1N1) Market Size (2016-2021) 5.5.2 Influenza Virus Vaccine (H1N1) Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) 5.5.4 Southeast Asia Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Influenza Virus Vaccine (H1N1) Market Size (2016-2021) 5.6.2 Influenza Virus Vaccine (H1N1) Key Players in Middle East (2016-2021) 5.6.3 Middle East Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) 5.6.4 Middle East Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Influenza Virus Vaccine (H1N1) Market Size (2016-2021) 5.7.2 Influenza Virus Vaccine (H1N1) Key Players in Africa (2016-2021) 5.7.3 Africa Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) 5.7.4 Africa Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Influenza Virus Vaccine (H1N1) Market Size (2016-2021) 5.8.2 Influenza Virus Vaccine (H1N1) Key Players in Oceania (2016-2021) 5.8.3 Oceania Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) 5.8.4 Oceania Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Influenza Virus Vaccine (H1N1) Market Size (2016-2021) 5.9.2 Influenza Virus Vaccine (H1N1) Key Players in South America (2016-2021) 5.9.3 South America Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) 5.9.4 South America Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Influenza Virus Vaccine (H1N1) Market Size (2016-2021) 5.10.2 Influenza Virus Vaccine (H1N1) Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) 5.10.4 Rest of the World Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) 6 Global Influenza Virus Vaccine (H1N1) Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Influenza Virus Vaccine (H1N1) Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Influenza Virus Vaccine (H1N1) Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Influenza Virus Vaccine (H1N1) Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Influenza Virus Vaccine (H1N1) Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Influenza Virus Vaccine (H1N1) Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Influenza Virus Vaccine (H1N1) Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Influenza Virus Vaccine (H1N1) Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Influenza Virus Vaccine (H1N1) Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Influenza Virus Vaccine (H1N1) Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Influenza Virus Vaccine (H1N1) Consumption by Countries 7 Global Influenza Virus Vaccine (H1N1) Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Influenza Virus Vaccine (H1N1) (2022-2027) 7.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) (2022-2027) 7.3 Global Forecasted Price of Influenza Virus Vaccine (H1N1) (2022-2027) 7.4 Global Forecasted Production of Influenza Virus Vaccine (H1N1) by Region (2022-2027) 7.4.1 North America Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027) 7.4.3 Europe Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027) 7.4.7 Africa Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027) 7.4.9 South America Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Application (2022-2027) 8 Global Influenza Virus Vaccine (H1N1) Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country 8.2 East Asia Market Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country 8.3 Europe Market Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Countriy 8.4 South Asia Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country 8.5 Southeast Asia Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country 8.6 Middle East Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country 8.7 Africa Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country 8.8 Oceania Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country 8.9 South America Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country 8.10 Rest of the world Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country 9 Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2027) 9.1 Global Influenza Virus Vaccine (H1N1) Historic Market Size by Type (2016-2021) 9.2 Global Influenza Virus Vaccine (H1N1) Forecasted Market Size by Type (2022-2027) 10 Global Influenza Virus Vaccine (H1N1) Consumption by Application (2016-2027) 10.1 Global Influenza Virus Vaccine (H1N1) Historic Market Size by Application (2016-2021) 10.2 Global Influenza Virus Vaccine (H1N1) Forecasted Market Size by Application (2022-2027) 11 Global Influenza Virus Vaccine (H1N1) Manufacturing Cost Analysis 11.1 Influenza Virus Vaccine (H1N1) Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1) 12 Global Influenza Virus Vaccine (H1N1) Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Influenza Virus Vaccine (H1N1) Distributors List 12.3 Influenza Virus Vaccine (H1N1) Customers 12.4 Influenza Virus Vaccine (H1N1) Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000